Adam Feuerstein of STAT tweeted following Johnson & Johnson’s (JNJ) pharmaceutical business update conference call: “I still believe $JNJ will drop $GERN imetelstat. I guess we wait for later this month to see if I’m right or wrong. Nothing today changes my bearish view. If anything, NOT focusing on imetelstat today is a negative.”
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.